Researchers identify rise in Guillain-Barré syndrome following AstraZeneca vaccine
New study reveals hundreds of new drug targets to combat tuberculosis
30 May 2022Sweetened and unsweetened coffee consumption associated with lower death risk
30 May 2022Researchers identify rise in Guillain-Barré syndrome following AstraZeneca vaccine
A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barré syndrome (GBS), has been identified by University College London (UCL) scientists, as part of an analysis of NHS data.
